Furthermore, a higher FoxP3+ T-lymphocyte tumor infiltration score has been proven to be a favorable prognostic factor in patients with colon cancer undergoing chemotherapy or chemoimmunotherapy [22]. The gene discussed is FOXP3; the disease is colonic neoplasm.